Shreyas Interm.

Who are in the management team of Shreyas Interm.?

As of March 2022, the management team of Shreyas Interm. includes Govind Krishna Sharma (Independent Director), Surya Prakash Pandey (Whole-time Director), Neelam Yashpal Arora (Independent Director), Bhavesh Vrujlal Gondaliya (Company Secretary & Compliance Officer), Dinesh Shankarlal Sharma (Non-Executive Director), and Nainesh Sumanti Rai Desai (Independent Director).

As of March 2022, the management team of Shreyas Interm. includes the following individuals:<BR><BR>1. Govind Krishna Sharma - Independent Director<BR>2. Surya Prakash Pandey - Whole-time Director<BR>3. Neelam Yashpal Arora - Independent Director<BR>4. Bhavesh Vrujlal Gondaliya - Company Secretary & Compliance Officer<BR>5. Dinesh Shankarlal Sharma - Non-Executive Director<BR>6. Nainesh Sumanti Rai Desai - Independent Director<BR><BR>These members play various roles within the company's governance and management structure.

Has Shreyas Interm. declared dividend?

No Dividend History Available

Who are the peers of the Shreyas Interm.?

Shreyas Interm.'s peers include Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Sh. Hari Chem., Gayatri BioOrga., Genus Prime, and Camex. In terms of returns, India Glycols leads with 150.27% over one year, while Shreyas Interm. has a return of -9.56%.

Peers: The peers of Shreyas Interm. are Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Sh. Hari Chem., Gayatri BioOrga., Genus Prime, and Camex.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL, while Good management risk is found at Chemplast Sanmar and Sh. Hari Chem., and Average management risk is noted at Tata Chemicals and India Glycols. Below Average management risk is present at Fischer Medical and Camex, while Gayatri BioOrga., Genus Prime, and Shreyas Interm. do not qualify. Growth is Good at Sh. Hari Chem., while Below Average growth is seen at Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, and Camex. Average growth is noted at Fischer Medical, and the rest do not qualify. Capital Structure is Excellent at GHCL, Good at Fischer Medical, Average at Tata Chemicals, and Below Average at Chemplast Sanmar, India Glycols, Sh. Hari Chem., and Camex, while the rest do not qualify.<BR><BR>Return Snapshot: The peer with the highest 1-year return is India Glycols at 150.27%, while the lowest is Tata Chemicals at -14.63%. Shreyas Interm.'s 1-year return is -9.56%, which is higher than Tata Chemicals but lower than the majority of its peers. Additionally, Camex and Tata Chemicals have negative six-month returns.

Is Shreyas Interm. overvalued or undervalued?

As of April 25, 2023, Shreyas Interm. is considered risky and overvalued due to negative earnings and unfavorable financial metrics, including a PE ratio of -42.92, while its year-to-date performance shows a decline of 23.72% compared to the Sensex's gain of 5.65%.

As of 25 April 2023, the valuation grade for Shreyas Interm. has moved from does not qualify to risky, indicating a significant change in its perceived financial health. The company appears to be overvalued based on its current metrics, with a PE ratio of -42.92, an EV to EBITDA of -75.07, and a Price to Book Value of 3.95. These ratios highlight the company's struggles, particularly with negative earnings and returns on capital employed and equity, which stand at -8.56% and -9.20%, respectively.<BR><BR>In comparison to its peers, Shreyas Interm. is positioned unfavorably against companies like Sudarshan Chemicals, which has a PE ratio of 71.32, and Kiri Industries, with a PE ratio of 13.72. This stark contrast further emphasizes the overvaluation of Shreyas Interm. Additionally, while the stock has shown a positive return of 3.85% over the past week compared to the Sensex's 1.45%, its year-to-date performance is concerning, with a decline of 23.72% against the Sensex's gain of 5.65%. Overall, the financial indicators suggest that Shreyas Interm. is overvalued in the current market environment.

What is the technical trend for Shreyas Interm.?

As of June 4, 2025, Shreyas Interm. shows a mildly bearish trend overall, with mixed signals from various indicators, including a mildly bullish weekly MACD and bearish monthly MACD.

As of 4 June 2025, the technical trend for Shreyas Interm. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The daily moving averages are mildly bearish, suggesting short-term weakness. The Bollinger Bands show a bullish signal on the weekly timeframe but are mildly bearish on the monthly. The KST indicates a mildly bullish trend weekly, but is mildly bearish monthly. Overall, the indicators present a mildly bearish stance with some mixed signals, particularly in the weekly timeframe.

What does Shreyas Interm. do?

Shreyas Intermediates Ltd manufactures dyes, pigments, and pigment intermediates in the Commodity Chemicals industry. As of March 2025, it reported a net profit of -3 Cr and has a market cap of INR 70 Cr.

Overview: <BR>Shreyas Intermediates Ltd is engaged in the manufacturing of Dyes, Pigments, and Pigment Intermediates within the Commodity Chemicals industry and operates as a Micro Cap company.<BR><BR>History: <BR>Shreyas Intermediates Ltd was incorporated as a Private Limited Company on November 6, 1989, and was converted into a Public Limited Company in April 1992. The latest quarterly results reported a net profit of -3 Cr for March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: -3 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 70 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 33 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.45 <BR>Return on Equity: -9.20% <BR>Price to Book: 4.04<BR><BR>Contact Details: <BR>Address: D-21 D-22 D-23 MIDC Inds Area, Lote Parshuram Taluka Khed Ratnagiri Maharashtra : 415722 <BR>Tel: 91-2356-272471 <BR>Email: accounts@shreyasintermediates.com <BR>Website: http://www.shreyaintermediates.co.in

Who are the top shareholders of the Shreyas Interm.?

The top shareholders of Shreyas Interm. include Kesar Petroproducts Limited with 27.59%, Invent Assets Securitisation And Reconstruction Pvt Ltd at 24.7%, and foreign institutional investors holding 8.53%. Promoter holdings are partially pledged at 10.028%.

The top shareholders of Shreyas Interm. include Kesar Petroproducts Limited, which holds the highest promoter stake at 27.59%. Additionally, the highest public shareholder is Invent Assets Securitisation And Reconstruction Pvt Ltd, with a holding of 24.7%. The company also has foreign institutional investors (FIIs) holding 8.53%, while individual investors account for 7.67% of the shares. Promoter holdings are partially pledged at 10.028%.

How big is Shreyas Interm.?

As of 24th July, Shreyas Intermediates Ltd has a market capitalization of 63.00 Cr and reported net sales of 0.00 Cr with a net loss of 1.57 Cr over the last four quarters. Shareholder's funds are valued at 17.98 Cr, and total assets amount to 25.76 Cr.

As of 24th July, <BR><BR>Market Cap: Shreyas Intermediates Ltd has a market capitalization of 63.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 0.00 Cr, while the sum of Net Profit for the same period shows a loss of 1.57 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is the latest annual period ending March 2024. Shareholder's Funds are valued at 17.98 Cr, and Total Assets amount to 25.76 Cr.

When is the next results date for Shreyas Interm.?

Shreyas Interm. will declare its results on 14 November 2025.

Shreyas Interm. will declare its results on 14 November 2025.

How has been the historical performance of Shreyas Interm.?

Shreyas Interm. has consistently reported zero net sales and persistent losses from March 2019 to March 2025, with negative operating profits and declining book value per share, indicating ongoing financial struggles and lack of revenue generation. Total liabilities and assets have also decreased during this period.

Answer:<BR>The historical performance of Shreyas Interm. shows consistent figures across several key financial metrics, primarily indicating a lack of operational revenue and persistent losses over the years.<BR><BR>Breakdown:<BR>Shreyas Interm. has reported zero net sales and other operating income from March 2019 to March 2025, resulting in total operating income remaining at 0.00 throughout this period. The company has incurred minimal employee costs, which have slightly increased from 0.00 in March 2019 to 0.02 in March 2025, while other expenses have fluctuated, peaking at 0.54 in March 2020 before declining to 0.39 in March 2023 and 0.39 in March 2025. Operating profit (PBDIT) has been negative, with losses ranging from -0.17 in March 2019 to -0.41 in March 2025. Profit before tax and profit after tax have also shown consistent losses, with figures of -1.59 in March 2025, reflecting a trend of increasing losses over the years. The company's total liabilities decreased from 31.64 in March 2020 to 24.66 in March 2025, while total assets followed a similar downward trend, falling from 31.64 to 24.66 in the same period. The book value per share has also declined from 2.82 in March 2020 to 1.75 in March 2025, indicating a deterioration in shareholder value. Overall, Shreyas Interm. has struggled with profitability and asset management, maintaining a stagnant operational status with no revenue generation.

Why is Shreyas Intermediates Ltd falling/rising?

As of 13-Feb, Shreyas Intermediates Ltd's stock price is rising to 8.08, reflecting a 3.46% increase. This rise is supported by strong daily performance, increased investor participation, and outperformance against its sector, despite a year-to-date decline.

As of 13-Feb, Shreyas Intermediates Ltd's stock price is rising, currently at 8.08, which reflects an increase of 0.27 or 3.46%. This upward movement is supported by a strong performance today, where the stock outperformed its sector by 4.8%. Additionally, the stock has shown a significant increase in investor participation, with a delivery volume of 11.05 k on 12 February, which is up by 76.36% compared to the 5-day average delivery volume. <BR><BR>In the context of recent performance, the stock has also experienced a notable rise over the past week, gaining 12.07%, while the benchmark Sensex has declined by 1.14%. This indicates that Shreyas Intermediates Ltd is gaining traction among investors despite its year-to-date decline of 16.70%. The current price is higher than the 5-day and 20-day moving averages, suggesting a short-term positive trend, although it remains below the longer-term moving averages of 50, 100, and 200 days. Overall, the combination of strong daily performance, increased investor interest, and relative outperformance against the sector contributes to the rising stock price of Shreyas Intermediates Ltd.

Should I buy, sell or hold Shreyas Intermediates Ltd?

Which are the latest news on Shreyas Interm.?

Are Shreyas Intermediates Ltd latest results good or bad?

Shreyas Intermediates Ltd's latest results are concerning, with zero revenue in Q3 FY26, a 100% decline from the previous quarter, and a net loss of ₹0.39 crores, reflecting significant operational challenges and making it a high-risk investment.

Shreyas Intermediates Ltd's latest results are concerning and can be classified as bad. In the third quarter of FY26, the company reported zero revenue generation, a stark decline from ₹10.37 crores in the previous quarter, marking a 100% sequential drop. This operational paralysis indicates severe challenges in maintaining production and sales.<BR><BR>Additionally, the company recorded a net loss of ₹0.39 crores, which is a 62.5% increase in losses compared to the previous quarter. The return on equity stands at a negative 7.84%, highlighting the company's inability to generate positive returns for shareholders. <BR><BR>Overall, the financial performance reflects significant operational difficulties, with a troubling pattern of intermittent revenue generation and consistent losses. The lack of clear strategies for recovery further exacerbates the situation, making it a high-risk investment.